HI
DNA icon

Harbour Investments’s Ginkgo Bioworks DNA Stock Holding History

Harbour Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850 Buy
86
+30
+54% +$251 ﹤0.01% 4258
2026
Q1 		$347 Buy
56
+17
+44% +$141 ﹤0.01% 4323
2025
Q4 		$324 Hold
39
– – ﹤0.01% 3613
2025
Q3 		$569 Buy
39
+19
+95% +$227 ﹤0.01% 3493
2025
Q2 		$225 Hold
20
– – ﹤0.01% 3462
2025
Q1 		$114 Hold
20
– – ﹤0.01% 3466
2024
Q4 		$196 Hold
20
– – ﹤0.01% 3369
2024
Q3 		$163 Hold
20
– – ﹤0.01% 3287
2024
Q2 		$267 Buy
20
+12
+150% +$358 ﹤0.01% 3148
2024
Q1 		$348 Buy
+8
New +$414 ﹤0.01% 3067
2022
Q4 		– Sell
-28
Closed -$3K – 3021
2022
Q3 		$3K Hold
28
– – ﹤0.01% 2302
2022
Q2 		$3K Buy
+28
New +$3.42K ﹤0.01% 2302
2021
Q4 		$4K Sell
13
-168
-93% -$79.8K ﹤0.01% 2221
2021
Q3 		$84K Buy
+181
New +$88.1K ﹤0.01% 1477

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Harbour Investments's DNA Position: Q2 2026 in Review

Harbour Investments increased its Ginkgo Bioworks (DNA) stake by 54% in Q2 2026, buying an estimated $251 and bringing the position to 86 shares worth $850. The position accounts for ﹤0.01% of the portfolio, ranked #4258.

Harbour Investments first reported a position in DNA in Q3 2021 and has held it in 14 quarters since. The position peaked at $84K in Q3 2021. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Harbour Investments held 86 shares of Ginkgo Bioworks worth $850 as of Q2 2026.
  • Harbour Investments bought 30 Ginkgo Bioworks shares in Q2 2026, an estimated $251.
  • Ginkgo Bioworks made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4258 holding.
  • Harbour Investments first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 14 quarters since.
  • Harbour Investments's Ginkgo Bioworks position peaked at $84K in Q3 2021.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.